Valuation: STCube, Inc.

Market Cap 505B 342M 301M 280M 257M 482M 33.13B 491M 3.34B 1.3B 16.16B 1.28B 1.26B 56.07B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 447B 303M 267M 248M 228M 427M 29.36B 435M 2.96B 1.16B 14.32B 1.14B 1.11B 49.69B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24/10/24 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
26/08/24 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
28/03/24 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
06/09/23 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
21/03/23 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
08/03/22 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
28/12/20 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
18/12/20 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
12/07/20 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
02/03/20 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
25/05/18 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
25/04/18 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
19/09/16 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day+2.77%
1 week-4.74%
Current month-14.00%
1 month-31.46%
3 months-54.58%
6 months+2.20%
Current year-9.39%
1 week 6,820
Extreme 6820
7,920
1 month 6,820
Extreme 6820
10,090
Current year 6,820
Extreme 6820
22,500
1 year 6,810
Extreme 6810
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 29/03/2013
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 01/03/2014
Director TitleAgeSince
Director/Board Member 61 01/03/2013
Director/Board Member 54 01/03/2013
Director/Board Member 62 01/03/2014
Date Insider Type Main position Quantity % Market Cap.
12/3/24 A
Bio Medical Holdings Corp.
BuyCompany 449,447 0.6892%
12/3/24 A Buy

Chief Financial Officer

47,582 0.0730%
12/3/24 A Buy

Chief Executive Officer

18,346 0.0281%
Change 5-day change 1-year change 3-year change Capi.($)
+2.77%-4.74%+3.19%-46.93% 333M
+0.21%-5.69%+32.47%+9.01% 107B
-0.71%-17.93%+225.27%+702.95% 45.19B
+0.49%+5.47%+137.43%+353.46% 46.53B
+0.29%-4.00%+88.16%+192.03% 36.16B
-0.45%+2.73%+18.57%+56.61% 30.14B
-1.72%+2.48%+132.62%+96.40% 30.3B
-0.40%-0.62%-23.61%-30.69% 22.14B
-0.33%-0.71%+12.72%+61.93% 18.5B
+0.58%-4.01%+34.36%+84.01% 13.73B
Average -0.01%+0.04%+66.12%+147.88% 35.02B
Weighted average by Cap. -0.18%-2.09%+79.97%+178.04%

Financials

2024 2025
Net sales 11.3B 7.66M 6.74M 6.26M 5.75M 10.79M 742M 10.99M 74.82M 29.18M 362M 28.75M 28.13M 1.25B 6.98B 4.73M 4.16M 3.87M 3.56M 6.67M 458M 6.79M 46.25M 18.04M 224M 17.77M 17.39M 776M
Net income -21.44B -14.53M -12.78M -11.87M -10.92M -20.48M -1.41B -20.84M -142M -55.38M -686M -54.55M -53.37M -2.38B -21.8B -14.78M -13M -12.07M -11.1M -20.82M -1.43B -21.2M -144M -56.31M -698M -55.48M -54.28M -2.42B
Net Debt -79.55B -53.92M -47.43M -44.06M -40.52M -75.99M -5.22B -77.35M -527M -205M -2.55B -202M -198M -8.84B -57.42B -38.92M -34.23M -31.8M -29.25M -54.85M -3.77B -55.83M -380M -148M -1.84B -146M -143M -6.38B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
23/07/26 7,430.00 +2.77% 152,752
22/07/26 ₩7,230.00 0.00% 195,626
21/07/26 ₩7,230.00 +3.29% 127,244
20/07/26 ₩7,000.00 -4.50% 192,999
16/07/26 ₩7,330.00 -6.03% 144,357
  1. Stock Market
  2. Stocks
  3. A052020 Stock